Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study
Rodríguez-Lescure, Álvaro, Gallego, Javier, Garcia-Alfonso, Pilar, Massuti, Bartomeu, Márquez, Raúl, Calvo, Lourdes, Sánchez-Rovira, Pedro, Antón, Antonio, Chacón, José Ignacio, Ciruelos, Eva, Ponce, Jose Juan, Santaballa, Ana, Valladares-Ayerbes, Manuel, Dueñas, María Rosario, Alonso, Vicente, Aparicio, Jorge, Encinas, Sara, Robles, Luis, Escudero, María José, Caballero, Rosalía, Bezares, Susana, de la Haba-Rodriguez, Juan
Published in Clinical & translational oncology (01.08.2024)
Published in Clinical & translational oncology (01.08.2024)
Get full text
Journal Article
Phase II Trial of Gemcitabine/Doxorubicin/Paclitaxel Administered Every Other Week in Patients with Metastatic Breast Cancer
Sánchez-Rovira, Pedro, Jaén, Ana, González, Encarnación, Porras, Ignacio, Dueñas, Maria Rosario, Medina, Begoña, Mohedano, Nicolás, Fernández, Margarita, Martos, Maximiliano, Lozano, Ana
Published in Clinical breast cancer (01.10.2000)
Published in Clinical breast cancer (01.10.2000)
Get full text
Journal Article